Mid Year Report 2020

DR ACCESS PRODUCTS ABOUT CITI DEPOSITARY RECEIPT SERVICES INTERNATIONAL INVESTING TRENDS GLOBAL DR TRENDS *Signifies Citi DR program capital raising. Deals in bold italics signify a JOBS Act Deal. 1 Defined as capital raising at the time of listing of additional DR securities including rights offerings, and private placements. Data as of June 30, 2020. 2 Industry as defined by Bloomberg. 3 Nucana capital raising comprised on 18 separate at-the-market transactions. Issuer Country Industry 2 USD Value (in Millions) Luckin Coffee Inc. China Food & Staples Retailing $667 argenx UK Pharmaceuticals, Biotech $642 Yageo Corporation* Taiwan Information Technology $650 Nio Inc China Automobiles & Components $428 Zai Lab Limited* China Pharmaceuticals, Biotech $328 Adaptimmune Therapeutics plc* UK Pharmaceuticals, Biotech $356 JSC NAC Kazatomprom* Kazakhstan Energy $197 Avadel Pharmaceuticals Plc Ireland Pharmaceuticals, Biotech $125 Hutchison China MediTech Limited Hong Kong Pharmaceuticals, Biotech $118 ArcelorMittal* Luxembourg Industrials, Metals & Mining $108 DBV Technologies S.A.* France Pharmaceuticals, Biotech $100 Autolus Therapeutics plc* UK Pharmaceuticals, Biotech $80 Itamar Medical Ltd Israel Health Care Services $40 Sequans Communications SA France Tech Hardware & Equip. $29 China Online Education Group China Commercial Services $19 Nano Dimension Ltd. Israel Tech Hardware & Equip. $17 Piedmont Lithium Ltd Australia Mining $13 Tiziana Life Sciences Plc UK Pharmaceuticals, Biotech $10 NuCana PLC* 3 UK Pharmaceuticals, Biotech $3 SAFE-T Group Limited Israel Software & Services $1 Medigus Ltd Israel Health Care Services $1 Grand Total $3,931 DR Follow-On Offerings 1 Source: Bloomberg and Depositary Data Interchange. 15 Citi Depositary Receipt Services Mid-Year 2020 Report